Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Genetic Signatures Ltd

GSS
Current price
0.72 AUD +0.01 AUD (+1.42%)
Last closed 0.71 AUD
ISIN AU000000GSS4
Sector Healthcare
Industry Diagnostics & Research
Exchange Australian Securities Exchange
Capitalization 165 339 942 AUD
Yield for 12 month +40.20 %
1Y
3Y
5Y
10Y
15Y
GSS
21.11.2021 - 28.11.2021

Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, SARS-CoV-2 respiratory plus, coronavirus, atypical respiratory, pertussis and PCP, parainfluenza 4, STI genital pathogen, extended spectrum beta-lactamase and carbapenemase producing organisms, viral meningitis, flavivirus dengue alphavirus, flavivirus reflex, dengue typing, and alphavirus reflex Detection kits under the EasyScreen name. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia. Address: Heart Research Institute, Newtown, NSW, Australia, 2042

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.71 AUD

P/E ratio

Dividend Yield

Current Year

+9 954 228 AUD

Last Year

+17 265 478 AUD

Current Quarter

+6 280 766 AUD

Last Quarter

+3 673 463 AUD

Current Year

+4 391 032 AUD

Last Year

-12 984 530 AUD

Current Quarter

-7 211 362 AUD

Last Quarter

-9 626 022 AUD

Key Figures GSS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -16 847 577 AUD
Operating Margin TTM -87.7 %
PE Ratio
Return On Assets TTM -19.69 %
PEG Ratio
Return On Equity TTM -34.34 %
Wall Street Target Price 1.71 AUD
Revenue TTM 14 033 362 AUD
Book Value 0.29 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -21.4 %
Dividend Yield
Gross Profit TTM 9 712 660 AUD
Earnings per share -0.11 AUD
Diluted Eps TTM -0.11 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 3.6 %
Profit Margin -129.74 %

Dividend Analytics GSS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GSS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GSS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 54.9451
Enterprise Value Revenue 13.023
Price Sales TTM 11.7819
Enterprise Value EBITDA -12.2935
Price Book MRQ 2.6548

Financials GSS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GSS

For 52 weeks

0.39 AUD 0.87 AUD
50 Day MA 0.67 AUD
Shares Short Prior Month
200 Day MA 0.7 AUD
Short Ratio
Shares Short
Short Percent